Factors affecting gentamicin pharmacokinetics in septic patients. 1999

G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
Department of Anesthesiology and Critical Care, Veterans General Hospital-Taipei and National Yang-Ming University, Taiwan, ROC.

BACKGROUND This prospective, comparative study was designed to estimate the volume of distribution (Vd) and elimination rate constant (K(e)) of gentamicin and to determine the clinical factors affecting the pharmacokinetics of gentamicin in different stages of sepsis. METHODS Seventy-seven critically ill patients treated with gentamicin for gram-negative sepsis were included. These septic patients were divided into hyperdynamic septic and hypodynamic septic groups according to cardiac index. Twenty-seven patients who received postoperative prophylactic gentamicin were recruited as controls. RESULTS Fifty-two patients in the hyperdynamic septic group had a significantly larger Vd than those in the hypodynamic septic and control groups. The Vd was correlated significantly with both Acute Physiological Score (APS) (r=0.340, P<0.01) and cardiac index (r=0.394, P<0.01). The K(e) of gentamicin correlated significantly with both blood urea nitrogen (BUN) (r= 0.565, P<0.01) and serum creatinine level (r=0.563, P<0.01). CONCLUSIONS The increased Vd in the septic patients was related to the severity of illness and magnitude of cardiac output. The K(e) of gentamicin was correlated with the serum creatinine level.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin

Related Publications

G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
April 2012, Journal of chemotherapy (Florence, Italy),
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
June 1980, Antimicrobial agents and chemotherapy,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
March 1986, Clinical pharmacology and therapeutics,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
July 1991, Antimicrobial agents and chemotherapy,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
January 2012, Cancer chemotherapy and pharmacology,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
June 1975, The Journal of antimicrobial chemotherapy,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
January 1977, The Journal of antimicrobial chemotherapy,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
June 1978, American journal of hospital pharmacy,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
January 1980, European journal of respiratory diseases. Supplement,
G J Tang, and J J Tang, and B S Lin, and C W Kong, and T Y Lee
January 1987, European journal of clinical pharmacology,
Copied contents to your clipboard!